Otrivine: Quality of Life (QoL) Impact in a Real-World Setting

Status Completed

Clinical Trial Summary

This study is designed to generate real world data from participants with nasal congestion acquired from common cold following treatment with a marketed nasal spray. The main purpose of this study is to evaluate the effectiveness of a nasal spray on quality of life (QoL) factors.

Clinical Trial Description

This is a longitudinal, open-label study evaluating the effect on QoL factors in participants with the common cold using Otrivine nasal spray (xylometazoline hydrochloride 0.1 percent [%]), in a real-world setting. A sufficient number of adults aged 18 years and over with symptoms of common cold will be screened for eligibility. The study expects to enroll approximately 125 participants to ensure that 100 participants complete the study. All study data will be collected remotely through a study app using the participant's own mobile device. ;

Study Design

Related Conditions & MeSH terms

Common Cold

Clinical Trial Details

NCT number	NCT05556148
Study type	Interventional
Source	HALEON
Contact
Status	Completed
Phase	Phase 4
Start date	November 7, 2022
Completion date	December 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05269290` - Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections	Phase 3
Completed	`NCT02451163` - DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly	Phase 2
Completed	`NCT01944631` - Iota-Carrageenan Nasal Spray in Common Cold	Phase 4
Completed	`NCT01651715` - Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections	Phase 1/Phase 2
Completed	`NCT00963443` - Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold	Phase 3
Completed	`NCT00778648` - Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms	N/A
Completed	`NCT00065715` - Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)	Phase 3
Completed	`NCT00032500` - Evaluation of Echinacea for the Common Cold	Phase 2
Not yet recruiting	`NCT05070650` - Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold	Phase 3
Completed	`NCT04144491` - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda	N/A
Not yet recruiting	`NCT04073511` - Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold	N/A
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Terminated	`NCT01964885` - Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections	Phase 3
Completed	`NCT01277081` - Effect of Paracetamol on the Common Cold	Phase 2
Completed	`NCT01728090` - Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections	Phase 4
Completed	`NCT00405509` - The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years	N/A
Completed	`NCT01033526` - Symptomatic Treatment of Common Cold Symptoms	Phase 4
Terminated	`NCT03339726` - Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold	Phase 2
Completed	`NCT01361399` - Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold	Phase 3
Recruiting	`NCT05244148` - Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects	N/A